NeuroVasc Technologies, Inc.

NeuroVasc Technologies, Inc. is a California-based medical device company founded in 2015, specializing in the development and commercialization of catheter-based technologies for neurovascular disease treatment, with particular focus on acute ischemic stroke management. The company leverages over 100 years of combined expertise in neurovascular device design and maintains regulatory clearance to serve patients in more than 35 countries. NeuroVasc's product portfolio includes novel mechanical thrombectomy systems, aspiration catheters, and micro/intermediate delivery catheters designed for endovascular intervention. The EnviSR is the company's flagship stent retriever for mechanical thrombectomy, supported by clinical evidence from IDE trials in the United States and pivotal randomized controlled trials in China. The company is actively advancing its pipeline through clinical development programs, including the ENVI RCT—a U.S. IDE clinical trial for ischemic stroke treatment. NeuroVasc manufactures devices meeting regulatory standards across multiple international markets, with products designed to address the growing clinical need for effective acute stroke intervention. The company's development strategy emphasizes innovation in catheter design, ease of use, and clinical efficacy for treating neurovascular emergencies.